GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Forward PE Ratio

BioNeutra Global (TSXV:BGA) Forward PE Ratio : 0.00 (As of Jun. 21, 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Forward PE Ratio?

BioNeutra Global's Forward PE Ratio for today is 0.00.

BioNeutra Global's PE Ratio without NRI for today is 0.00.

BioNeutra Global's PE Ratio for today is 0.00.


BioNeutra Global Forward PE Ratio Historical Data

The historical data trend for BioNeutra Global's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Forward PE Ratio Chart

BioNeutra Global Annual Data
Trend
Forward PE Ratio

BioNeutra Global Quarterly Data
Forward PE Ratio

Competitive Comparison of BioNeutra Global's Forward PE Ratio

For the Packaged Foods subindustry, BioNeutra Global's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNeutra Global's Forward PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's Forward PE Ratio falls into.



BioNeutra Global Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


BioNeutra Global  (TSXV:BGA) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


BioNeutra Global Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global (TSXV:BGA) Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines